Amanote Research
Register
Sign In
Drug Company Merger Should Benefit Research
BMJ
doi 10.1136/bmj.316.7130.493c
Full Text
Open PDF
Abstract
Available in
full text
Date
February 14, 1998
Authors
G. Labreque
Publisher
BMJ
Related search
Company Performance Before and After a Merger
Benefit Design Should Reflect Value
NAM Perspectives
Merger Mooted in UK Research
Nature
Multidisciplinary
Manchester Merger to Spawn Research Giant
Nature
Multidisciplinary
Quantifying Preferences in Drug Benefit‐Risk Decisions
Clinical Pharmacology and Therapeutics
Pharmacology
Drug Company Targets US State Health Officials
British Medical Journal
Medicine
Unreported Cholesterol Drug Data Released by Company
BMJ
Nurse Review Paves Way for Merger of UK Research Councils
The Lancet
Medicine
Newly Established Drug Delivery Systems Company Database
Journal of Korean Pharmaceutical Sciences
